Biovie Inc Stock Performance
| BIVI Stock | USD 0.49 0.01 2.08% |
The firm shows a Beta (market volatility) of 2.44, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Biovie will likely underperform. Biovie Inc has an expected return of -0.53%. Please make sure to confirm Biovie Inc potential upside, as well as the relationship between the rate of daily change and relative strength index , to decide if Biovie Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Biovie Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in May 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
Last Split Factor 1:125 | Dividend Date 2019-11-22 | Last Split Date 2019-11-22 |
1 | BioVie Inc. Sued for Securities Law Violations - Investors Should Contact Levi Korsinsky Before March 19, 2024 to Discuss Your Rights - BIVI | 03/12/2024 |
2 | Levi Korsinsky Notifies Shareholders of BioVie Inc. of a Class Action Lawsuit and an Upcoming Deadline | 03/14/2024 |
3 | The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioVie Inc. | 03/18/2024 |
4 | BioVie Inc. Sued for Securities Law Violations - Contact Levi Korsinsky Before March 19, 2024 to Discuss Your Rights - BIVI | 03/19/2024 |
5 | Insider Trading | 04/05/2024 |
| Begin Period Cash Flow | 18.6 M | |
| Total Cashflows From Investing Activities | -14.3 M |
Biovie |
Biovie Relative Risk vs. Return Landscape
If you would invest 94.00 in Biovie Inc on January 25, 2024 and sell it today you would lose (45.00) from holding Biovie Inc or give up 47.87% of portfolio value over 90 days. Biovie Inc is currently does not generate positive expected returns and assumes 9.97% risk (volatility on return distribution) over the 90 days horizon. In different words, 88% of stocks are less volatile than Biovie, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Biovie Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biovie's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Biovie Inc, and traders can use it to determine the average amount a Biovie's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0532
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BIVI |
Estimated Market Risk
| 9.97 actual daily | 88 88% of assets are less volatile |
Expected Return
| -0.53 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Biovie is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biovie by adding Biovie to a well-diversified portfolio.
Biovie Fundamentals Growth
Biovie Stock prices reflect investors' perceptions of the future prospects and financial health of Biovie, and Biovie fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biovie Stock performance.
| Return On Equity | -2.58 | ||||
| Return On Asset | -0.81 | ||||
| Current Valuation | 9.29 M | ||||
| Shares Outstanding | 54.92 M | ||||
| Price To Earning | 18.12 X | ||||
| Price To Book | 3.80 X | ||||
| EBITDA | (44.29 M) | ||||
| Net Income | (50.26 M) | ||||
| Cash And Equivalents | 18.64 M | ||||
| Cash Per Share | 0.62 X | ||||
| Total Debt | 14.42 M | ||||
| Debt To Equity | 3.34 % | ||||
| Current Ratio | 4.50 X | ||||
| Book Value Per Share | 0.19 X | ||||
| Cash Flow From Operations | (40.25 M) | ||||
| Earnings Per Share | (1.17) X | ||||
| Market Capitalization | 27.01 M | ||||
| Total Asset | 35.1 M | ||||
| Retained Earnings | (301.23 M) | ||||
| Working Capital | 19.55 M | ||||
| Current Asset | 9 K | ||||
| Current Liabilities | 961 K | ||||
About Biovie Performance
To evaluate Biovie Inc Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Biovie generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Biovie Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Biovie Inc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Biovie's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.00 | 0.00 | |
| Return On Tangible Assets | (1.33) | (1.39) | |
| Return On Capital Employed | (2.52) | (2.64) | |
| Return On Assets | (1.65) | (1.73) | |
| Return On Equity | (3.77) | (3.96) |
Things to note about Biovie Inc performance evaluation
Checking the ongoing alerts about Biovie for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Biovie Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biovie Inc generated a negative expected return over the last 90 days | |
| Biovie Inc has high historical volatility and very poor performance | |
| Biovie Inc has some characteristics of a very speculative penny stock | |
| Biovie Inc has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (50.26 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Biovie Inc currently holds about 18.64 M in cash with (40.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.62, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Biovie Inc has a frail financial position based on the latest SEC disclosures | |
| Roughly 43.0% of the company shares are held by company insiders |
- Analyzing Biovie's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biovie's stock is overvalued or undervalued compared to its peers.
- Examining Biovie's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biovie's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biovie's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Biovie's stock. These opinions can provide insight into Biovie's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Biovie Stock analysis
When running Biovie's price analysis, check to measure Biovie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovie is operating at the current time. Most of Biovie's value examination focuses on studying past and present price action to predict the probability of Biovie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovie's price. Additionally, you may evaluate how the addition of Biovie to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is Biovie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biovie. If investors know Biovie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biovie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Return On Assets (0.81) | Return On Equity (2.58) |
The market value of Biovie Inc is measured differently than its book value, which is the value of Biovie that is recorded on the company's balance sheet. Investors also form their own opinion of Biovie's value that differs from its market value or its book value, called intrinsic value, which is Biovie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biovie's market value can be influenced by many factors that don't directly affect Biovie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biovie's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biovie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biovie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.